RSS   Newsletter   Contact   Advertise with us
Post Online Media

Entasis Therapeutics appoints Greg Norden to board

Entasis TherapeuticsEntasis Therapeutics, a pharmaceutical company, announced the appointment of Greg Norden to the company’s board of directors.

Mr. Norden brings more than 20 years of leadership and financial management experience in global healthcare and pharmaceuticals.

Mr. Norden is currently the Managing Director of G9 Capital Group which invests in early stage ventures and provides corporate finance advisory services.

From 1989 to 2010, Mr. Norden held various senior positions with Wyeth/American Home Products, most recently as Wyeth's Senior Vice President and Chief Financial Officer.

Prior to this role, he was Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals. He began his career at Arthur Andersen & Co. and served as an Audit Manager.

Mr. Norden serves on several Boards including: NanoString, Royalty Pharma, Univision, and Zoetis.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy